Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2025-05-12
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mid-term Effect of a Novel Sit-to-stand Workplace (ACTIVE OFFICE) on Cognitive and Physiological Parameters
NCT02825303
Reducing Sedentary Behaviour in Office Workers
NCT03845803
Assessment of All Spine Segments ın Individuals With Low Back Pain
NCT06276322
The Impact of Prolonged Standing on Musculoskeletal Pain
NCT03678623
Seating Posture and Its Relation to Pain
NCT06579131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study consists of a pre-screening visit and 4 assessment days / visits. After proving eligibility for the study (inclusion/exclusion criteria), subjects are assigned to one of the two study tracks. Subjects are randomised to one of the two study tracks and then to the respective group (Group A to D).
* Study track 1: saddle chair with standard pendulum mechanism (= intervention 1) + static office chair (= control)
* Study track 2: office swivel chair with integrated newly developed pendulum mechanism (= intervention 2) + static office chair (= control).
Depending on the study track and group allocation, the test subjects first receive a dynamic office chair (= intervention) or a static office chair (= control). The randomization will be realized with opaque envelopes in different colours and follows international recommendations.
Overall participants will execute identical assessments. A wash-put period between the control and the intervention phases ensures identical baseline conditions. The overall duration of study participation equals 16 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Track 1: Group A
The pre-existing static office chair will be used in the personal workplace for the first 6 weeks within the first half of the study. A wash-out period of a minimum of 4 weeks will be executed after the first half of the study. A dynamic office chair (saddle chair with standard pendulum mechanism) will be used on the personal workstation for 6 weeks within the second half of the study after the wash-out period.
Dynamic office chair (saddle chair with standard pendulum mechanism)
The dynamic office chair has a typical office chair design (e.g. seat pan and a lumbar support). The seat pan is mounted on a flexible mechanic construction that allows hip movements in the frontal plane while sitting.
Study Track 1: Group B
A dynamic office chair (saddle chair with standard pendulum mechanism) will be used in the personal workplace for the first 6 weeks within the first half of the study. A wash-out period of a minimum of 4 weeks will be executed after the first half of the study. The pre-existing static office chair will be used on the personal workstation for 6 weeks within the second half of the study after the wash-out period.
Dynamic office chair (saddle chair with standard pendulum mechanism)
The dynamic office chair has a typical office chair design (e.g. seat pan and a lumbar support). The seat pan is mounted on a flexible mechanic construction that allows hip movements in the frontal plane while sitting.
Study Track 2: Group C
The pre-existing static office chair will be used in the personal workplace for the first 6 weeks within the first half of the study. A wash-out period of a minimum of 4 weeks will be executed after the first half of the study. A dynamic office chair (office swivel chair with integrated newly developed pendulum mechanism) will be used on the personal workstation for 6 weeks within the second half of the study after the wash-out period.
Dynamic Office Chair (office swivel chair with integrated newly developed pendulum mechanism)
The dynamic office chair has a typical office chair design (e.g. seat pan and a lumbar support). The seat pan is mounted on a flexible mechanic construction that allows hip movements in the frontal plane while sitting.
Study Track 2: Group D
A dynamic office chair (office swivel chair with integrated newly developed pendulum mechanism) will be used in the personal workplace for the first 6 weeks within the first half of the study. A wash-out period of a minimum of 4 weeks will be executed after the first half of the study. The pre-existing static office chair will be used on the personal workstation for 6 weeks within the second half of the study after the wash-out period.
Dynamic Office Chair (office swivel chair with integrated newly developed pendulum mechanism)
The dynamic office chair has a typical office chair design (e.g. seat pan and a lumbar support). The seat pan is mounted on a flexible mechanic construction that allows hip movements in the frontal plane while sitting.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynamic office chair (saddle chair with standard pendulum mechanism)
The dynamic office chair has a typical office chair design (e.g. seat pan and a lumbar support). The seat pan is mounted on a flexible mechanic construction that allows hip movements in the frontal plane while sitting.
Dynamic Office Chair (office swivel chair with integrated newly developed pendulum mechanism)
The dynamic office chair has a typical office chair design (e.g. seat pan and a lumbar support). The seat pan is mounted on a flexible mechanic construction that allows hip movements in the frontal plane while sitting.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People aged between 18 and 65 years
* People classified as pain developers (e.g.: a 10 mm increase in pain on a 100 mm paper-based VAS)
* Office workers
* Employment status: \> 25 h / week
* Sufficient knowledge of German (min. B2 level)
* Body height of at least 160cm required
* Electrically or manually height-adjustable table at main workstation
Exclusion Criteria
* Pregnancy
* Sitting for less than 20 hours per week at the main workplace
* Body weight over 110 kg and a body height over 195 cm
* Regular therapy or medication for pain or medication that affects the perception of pain (e.g. certain psychotropic drugs according to the package leaflet)
* office chair to which it is not possible to attach the swivel mechanism prototype
* Presence of any chronic disease that may influence pain perception (e.g., chronic kidney disease, fibromyalgia, neuropathy, chronic fatigue syndrome)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Applied Sciences for Health Professions Upper Austria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Applied Sciences for Health Professions Upper Austria
Linz, Upper Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-05-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.